Vaccine rollout in England prevented 10,400 deaths by end-March, study says

LONDON (Reuters) - England's fast rollout of COVID-19 vaccines prevented over 10,000 deaths of people aged 60 and older by the end of March, according to an analysis by Public Health England. England experienced a peak in infections, hospitalisations and deaths in January, but the toll would have been even worse without the rapid vaccination programme that began on Dec. 8, according to the study.

Reuters April 09, 2021 04:11:03 IST
Vaccine rollout in England prevented 10,400 deaths by end-March, study says

Vaccine rollout in England prevented 10400 deaths by endMarch study says

LONDON (Reuters) - England's fast rollout of COVID-19 vaccines prevented over 10,000 deaths of people aged 60 and older by the end of March, according to an analysis by Public Health England.

England experienced a peak in infections, hospitalisations and deaths in January, but the toll would have been even worse without the rapid vaccination programme that began on Dec. 8, according to the study.

Over 15 million doses of vaccine were given to adults aged 60 and over in England by the end of March, preventing an estimated 10,400 deaths, mostly among those aged 80 and over, Public Health England said.

The analysis compared the reported number of deaths up to the March period with the number that would have been expected had vaccines not been delivered at that time.

Close to 127,000 people have died within 28 days of testing positive for COVID-19 in the United Kingdom.

The vaccination campaign accelerated in March. A total of 31.8 million people across the United Kingdom have had at least one dose, while 6.1 million people have had two.

(Reporting by Estelle Shirbon; Editing by Kate Holton)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

How Biden's agencies are picking apart Trump's Wall Street-friendly measures
Business

How Biden's agencies are picking apart Trump's Wall Street-friendly measures

(In first paragraph, fixes hyperlink to story) By Katanga Johnson WASHINGTON (Reuters) -U.S.

GM marketing spend will return to normal levels post pandemic
Business

GM marketing spend will return to normal levels post pandemic

By Ben Klayman DETROIT (Reuters) - General Motors Co's marketing and promotional spending will return to normal levels after the COVID-19 pandemic caused that budget to drop last year, the U.S. automaker's top marketing officer said on Monday. "What we went through in the pandemic was certainly severe and we should be moving back up to our normalized levels," GM Chief Marketing Officer Deborah Wahl said in an online appearance at a Reuters Events conference.

White House to zero in on chip shortage in meeting with company officials
Business

White House to zero in on chip shortage in meeting with company officials

By Nandita Bose WASHINGTON (Reuters) - U.S. President Joe Biden will urge Congress to invest $50 billion in semiconductor manufacturing and research when he meets with top executives from nearly 20 major companies on Monday about the global chips shortage that has roiled the automotive industry and technology firms. The push is part of his broader focus on rebuilding U.S